How Do Protein Synthesis Inhibitors Affect Public Health Policies?
Public health policies must balance the need to use protein synthesis inhibitors to control infections with the risk of developing resistance. Guidelines for the appropriate use of antibiotics, surveillance programs to monitor resistance patterns, and the development of new therapeutic agents are all critical components of public health strategies. Policies must also address the ethical considerations of antibiotic use in agriculture and the impact on human health.
